Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next‐generation sequencing approach

We applied a highly sensitive next‐generation sequencing method to identify lymphoma‐specific immunoglobulin gene segments in classical Hodgkin lymphoma (CHL) at initial diagnosis or recurrence, and assessed the ability of detecting such lymphoma‐specific sequences in peripheral blood (PB). Seventeen CHL cases were tested and lymphoma‐specific sequences were identified in 12 of the primary tumour biopsies. In 11 of these patients whose paired PB samples were available, tumour‐specific clonotypes were detected in PB in eight patients. This data demonstrates the feasibility of detecting circulating tumour‐specific sequences, creating an unprecedented opportunity to optimize the future treatment and monitoring strategies for patients with CHL.

[1]  A. Palumbo,et al.  Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders , 2014, Leukemia.

[2]  R. Vij,et al.  Deep sequencing reveals myeloma cells in peripheral blood in majority of multiple myeloma patients. , 2014, Clinical lymphoma, myeloma & leukemia.

[3]  A. LaCasce,et al.  Detection of circulating tumour DNA in patients with aggressive B‐cell non‐Hodgkin lymphoma , 2013, British journal of haematology.

[4]  B. Narasimhan,et al.  Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia , 2013, Leukemia.

[5]  D. Campana,et al.  Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. , 2012, Blood.

[6]  V. Carlton,et al.  Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. , 2012, Blood.

[7]  A. Moskowitz Novel Agents in Hodgkin Lymphoma , 2012, Current Oncology Reports.

[8]  R. Advani,et al.  Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[9]  M. Siedner,et al.  Circulating clonotypic B cells in classic Hodgkin lymphoma. , 2009, Blood.

[10]  H. Stein,et al.  Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. , 2000, Blood.

[11]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Pileri,et al.  Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. , 1997, The New England journal of medicine.

[13]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells , 1996, The Journal of experimental medicine.

[14]  R Fischer,et al.  Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Kuruvilla Standard therapy of advanced Hodgkin lymphoma. , 2009, Hematology. American Society of Hematology. Education Program.